Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Iodine	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Failure	O
to	O
Thrive,	O
hyperglycemia,	O
hyponatremia,	O
CAP	B-Lower_respiratory_tract_infection
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
none	O
History	O
of	O
Present	O
Illness:	O
Mr.	O
___	O
is	O
a	O
___	O
year-old	O
male	O
with	O
history	O
of	O
CLL,	O
Stage	O
III	O
CKD,	O
CAD	O
s/p	O
CABG	O
who	O
presented	O
to	O
the	O
ED	O
this	O
evening	O
with	O
failure	O
to	O
thrive.	O
The	O
patient	O
and	O
his	O
wife	B-Lives_alone
were	O
brought	O
to	O
the	O
ED	O
after	O
urging	O
from	O
his	O
son	O
and	O
PCP	O
due	O
to	O
multiple	O
issues.	O
His	O
wife	O
has	O
been	O
very	O
depressed	O
recently	O
and	O
is	O
currently	O
being	O
admitted	O
to	O
___.	O
He	O
had	O
not	O
been	O
taking	O
his	O
medications	O
for	O
the	O
last	O
2	O
days.	O
In	O
the	O
ED,	O
initial	O
VS:	O
T	O
98.1	O
P	O
67	O
BP	O
158/71	O
RR	O
18	O
Sat	O
99%.	O
He	O
had	O
a	O
chest	O
X-ray	O
which	O
showed	O
possible	O
LUL	O
PNA	B-Lower_respiratory_tract_infection
per	O
radiology	O
and	O
mild	O
leukocytosis	O
on	O
CBC.	O
Also	O
was	O
hyperglycemic	O
and	O
hyponatremic.	O
Cultures	O
were	O
sent.	O
He	O
was	O
given	O
500	O
mg	O
azithromycin	O
and	O
1	O
gram	O
ceftriaxone	O
as	O
well	O
as	O
40	O
mg	O
IV	O
lasix,	O
10	O
units	O
regular	O
insulin,	O
6	O
units	O
of	O
humalog,	O
and	O
20	O
mg	O
omeprazole.	O
He	O
was	O
also	O
given	O
2	O
L	O
NS.	O
He	O
is	O
being	O
admitted	O
to	O
medicine	O
for	O
further	O
evaluation.	O
On	O
arrival	O
to	O
the	O
floor	O
he	O
denies	O
current	O
symptoms.	O
He	O
states	O
his	O
wife	O
usually	O
keeps	O
track	O
of	O
his	O
medications	O
and	O
reminds	O
him	O
to	O
take	O
them,	O
but	O
due	O
to	O
her	O
depression	O
she	O
has	O
not	O
been	O
preforming	O
this	O
task	O
and	O
he	O
has	O
not	O
been	O
taking	O
his	O
medications.	O
He	O
also	O
notes	O
a	O
10	O
pound	O
weight	B-Weight_loss
loss	B-Weight_loss
over	O
the	O
past	O
couple	O
of	O
months.	O
Admits	O
to	O
normal	O
appetite,	O
but	O
states	O
his	O
wife	B-Lives_alone
___	O
been	O
cooking	O
as	O
much	O
so	O
he's	O
taking	O
more	O
irregular	O
meals.	O
He	O
has	O
noted	O
increased	O
urination	O
recently,	O
denies	O
increased	O
thirst	O
or	O
dysuria.	O
Also	O
admits	O
to	O
dyspnea	O
on	O
exertion,	O
constipation,	B-Constipation
and	O
feeling	O
cold	O
recently.	O
No	O
cough	O
or	O
fevers	O
noted.	O
He	O
notes	O
his	O
lower	O
extremity	O
edema	O
has	O
decreased.	O
He	O
denies	O
depression	O
currently.	O
Past	O
Medical	O
History:	O
-	O
Chronic	O
lymphocytic	O
lymphoma	O
-	O
Type	O
2	O
diabetes	O
mellitus	O
complicated	O
by	O
neuropathy	O
and	O
nephropathy	O
-	O
Stage	O
III	O
CKD	O
-	O
history	O
of	O
hyperkalemia	O
-	O
Peripheral	O
vascular	O
disease	O
-	O
Coronary	O
artery	O
disease	O
s/p	O
CABGx4	O
-	O
history	O
of	O
depression	O
-	O
Mild	O
coginitive	O
impairment	O
-	O
___	O
-	O
s/p	O
R	O
total	O
hip	O
replacement	O
-	O
s/p	O
R	O
knee	O
surgery	O
-	O
s/p	O
R	O
ankle	O
repair	O
-	O
s/p	O
R	O
inguinal	O
hernia	O
repair	O
-	O
s/p	O
R	O
VATS	O
with	O
pleural	O
biopsy	O
-	O
s/p	O
Bilateral	O
cataract	O
surgery	O
Social	O
History:	O
___	O
Family	O
History:	O
Significant	O
for	O
mother	O
with	O
diabetes	O
and	O
father	O
with	O
CAD.	O
Physical	O
Exam:	O
ADMISSION	O
EXAM:	O
VS:	O
T	O
96.1	O
BP	O
151/83	O
P	O
73	O
RR	O
20	O
Sat	O
100%	O
on	O
RA	O
General:	O
Elderly	O
male	O
laying	O
in	O
bed	O
in	O
NAD.	O
Alert	O
and	O
oriented	B-Delirium
to	O
person,	O
place,	O
and	O
time.	O
HEENT:	O
Sclera	O
anicteric,	O
adentulous,	O
MM	O
dry,	O
oropharynx	O
clear	O
Neck:	O
supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
Lungs:	O
Breathing	O
comfortably.	O
A	O
few	O
scattered	O
crackles,	O
but	O
not	O
reproducible.	O
CV:	O
RRR,	O
___	O
systolic	O
murmur	O
present.	O
Abdomen:	O
+	O
BS,	O
soft	O
NTND	O
Ext:	O
warm,	O
well	O
perfused,	O
1	O
+	O
pitting	O
edema	O
of	O
his	O
lower	O
extremities	O
bilaterally	O
with	O
venous	O
stasis	O
changes	O
present.	O
Neuro:	O
CN	O
II-XI	O
intact,	O
___	O
strength	O
in	O
his	O
upper	O
and	O
lower	O
extremities	O
b/l,	O
sensation	O
to	O
light	O
touch	O
intact	O
throughout	O
.	O
DISCHARGE	O
EXAM:	O
VS:	O
T	O
97.0	O
BP	O
140/73	O
P	O
64	O
RR	O
18	O
Sat	O
98%	O
on	O
RA	O
General:	O
Elderly	O
male	O
laying	O
in	O
bed	O
in	O
NAD.	O
Alert	O
and	O
oriented	B-Delirium
to	O
person,	O
place,	O
and	O
time.	O
HEENT:	O
Sclera	O
anicteric,	O
adentulous,	O
MM	O
dry,	O
oropharynx	O
clear	O
Neck:	O
supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
Lungs:	O
Breathing	O
comfortably.	O
A	O
few	O
scattered	O
crackles,	O
but	O
not	O
reproducible.	O
CV:	O
RRR,	O
___	O
systolic	O
murmur	O
present.	O
Abdomen:	O
+	O
BS,	O
soft	O
NTND	O
Ext:	O
warm,	O
well	O
perfused,	O
no	O
pedal	O
edema,	O
ulcers	O
on	O
___	O
(0.4	O
cm)	O
and	O
___	O
(0.6cm)	O
toes	O
on	O
right	O
foot,	O
surrounding	O
errythema	O
Neuro:	O
CN	O
II-XI	O
intact,	O
___	O
strength	O
in	O
his	O
upper	O
and	O
lower	O
extremities	O
b/l,	O
decreased	O
sensation	O
in	O
feet	O
bilaterally	O
Pertinent	O
Results:	O
===================	O
LABORATORY	O
RESULTS	O
===================	O
ADMISSION	O
LABS:	O
___	O
01:00PM	O
BLOOD	O
WBC-14.2*	O
RBC-3.44*	O
Hgb-9.7*	O
Hct-28.8*	O
MCV-84	O
MCH-28.2	O
MCHC-33.7	O
RDW-14.1	O
Plt	O
___	O
___	O
01:00PM	O
BLOOD	O
Neuts-46.1*	O
Lymphs-47.8*	O
Monos-3.4	O
Eos-2.4	O
Baso-0.3	O
___	O
01:00PM	O
BLOOD	O
Ret	O
Aut-1.9	O
___	O
01:00PM	O
BLOOD	O
Glucose-611*	O
UreaN-44*	O
Creat-1.9*	O
Na-125*	O
K-4.3	O
Cl-93*	O
HCO3-26	O
AnGap-10	O
___	O
01:11PM	O
BLOOD	O
Glucose-584*	O
Lactate-1.3	O
.	O
DISCHARGE	O
LABS:	O
___	O
06:25AM	O
BLOOD	O
WBC-17.4*	O
RBC-3.88*	O
Hgb-10.7*	O
Hct-32.0*	O
MCV-82	O
MCH-27.4	O
MCHC-33.3	O
RDW-14.1	O
Plt	O
___	O
___	O
06:25AM	O
BLOOD	O
Glucose-151*	O
UreaN-48*	O
Creat-1.6*	O
Na-140	O
K-5.0	O
Cl-103	O
HCO3-29	O
AnGap-13	O
___	O
06:25AM	O
BLOOD	O
Calcium-8.9	O
Phos-4.5	O
Mg-1.9	O
===============	O
OTHER	O
STUDIES	O
===============	O
Chest	O
Radiograph	O
___:	O
IMPRESSION:	O
Left	O
mid	O
lung	O
opacity,	O
new	O
from	O
___	O
and	O
concerning	O
for	O
pneumonia.	B-Lower_respiratory_tract_infection
Followup	O
radiographs	O
following	O
treatment	O
of	O
acute	O
illness	O
are	O
recommended	O
to	O
evaluate	O
for	O
resolution	O
of	O
this	O
finding.	O
Scattered	O
pleural	O
plaques,	O
unchanged	O
from	O
multiple	O
prior	O
studies.	O
.	O
===============	O
MICROBIOLOGY	O
===============	O
Urine	O
culture	O
negative	O
Blood	O
cx	O
x2	O
pending	O
at	O
time	O
of	O
discharge.	O
Brief	O
Hospital	O
Course:	O
___	O
year-old	O
male	O
with	O
history	O
of	O
CLL,	O
Stage	O
III	O
CKD,	O
CAD	O
s/p	O
CABG	O
who	O
presented	O
to	O
the	O
ED	O
with	O
failure	O
to	O
thrive	O
and	O
was	O
found	O
to	O
be	O
hyperglycemic,	O
hyponatremic,	O
and	O
to	O
have	O
a	O
community-acquired	B-Lower_respiratory_tract_infection
PNA	B-Lower_respiratory_tract_infection
on	O
CXR.	O
.	O
#	O
Community-acquired	B-Lower_respiratory_tract_infection
PNA:	B-Lower_respiratory_tract_infection
The	O
patient	O
was	O
admitted	O
with	O
a	O
mild	O
leukocytosis	O
with	O
a	O
left	O
shift	O
as	O
well	O
as	O
a	O
new	O
infiltrate	O
on	O
CXR.	O
He	O
reported	O
feeling	O
cold,	O
though	O
had	O
not	O
checked	O
his	O
temperature	O
recently.	O
He	O
was	O
treated	O
with	O
azithromycin	O
and	O
ceftriaxone	O
while	O
in	O
house.	O
Ceftriaxone	O
was	O
discontinued	O
on	O
discharge	O
as	O
patient	O
was	O
clinically	O
stable.	O
Azithromycin	O
was	O
discontinued	O
once	O
pt	O
was	O
started	O
on	O
levaquin	O
(see	O
below).	O
Pt	O
was	O
maintained	O
on	O
RA	O
during	O
his	O
hospitalization	O
and	O
did	O
not	O
require	O
oxygen	O
supplementation.	O
Blood	O
cultures	O
were	O
no	O
growth	O
to	O
date	O
at	O
time	O
of	O
discharge.	O
.	O
#	O
diabetic	O
foot	O
ulcer:	O
pt	O
noticed	O
to	O
have	O
ulcer	O
between	O
third	O
and	O
forth	O
toe	O
on	O
right	O
foot.	O
The	O
___	O
toe	O
ulcer	O
is	O
round	O
and	O
approx	O
0.4	O
cm	O
with	O
pink	O
base.	O
There	O
is	O
periwound	O
maceration.	O
The	O
___	O
toe	O
ulcer	O
is	O
approx	O
0.6	O
cm	O
and	O
has	O
a	O
yellow	O
wound	O
bed.	O
The	O
toe	O
was	O
faintly	O
erythematous.	O
There	O
was	O
no	O
odor	O
to	O
either	O
toe	O
ulcer.	O
The	O
pt	O
has	O
neuropathy	O
and	O
does	O
not	O
feel	O
pain	O
to	O
foot.	O
He	O
was	O
started	O
on	O
bactrim	O
and	O
levoquin	O
for	O
treatment	O
of	O
diabetic	O
ulcers	O
and	O
was	O
evaluated	O
by	O
wound	O
care	O
who	O
recommended	O
the	O
following	O
treatments:	O
cleanse	O
skin/ulcer	O
and	O
pat	O
dry,	O
apply	O
aloe	O
vesta	O
moisturizer	O
to	O
intact	O
dry	O
skin,	O
cover	O
wounds	O
with	O
small	O
piece	O
of	O
aquacel	O
ag	O
sheet	O
followed	O
by	O
dry	O
gauze	O
then	O
ABD	O
pad,	O
wrap	O
with	O
Kerlix	O
or	O
conform,	O
change	O
daily.	O
He	O
should	O
follow	O
up	O
with	O
podiatry	O
.	O
#	O
Hyponatremia:	O
The	O
patient	O
presented	O
with	O
new	O
hyponatremia	O
with	O
a	O
sodium	O
of	O
125.	O
Given	O
his	O
history	O
of	O
polyuria	O
with	O
elevated	O
serum	O
glucose	O
levels	O
and	O
decreased	O
peripheral	O
edema,	O
most	O
likely	O
this	O
was	O
hypovolemic	O
hyponatremia.	O
He	O
received	O
2	O
L	O
NS	O
and	O
his	O
sodium	O
normalized.	O
His	O
sodium	O
remained	O
stable	O
for	O
remainder	O
of	O
hospital	O
course.	O
.	O
#	O
Social/Home	O
Issues:	O
The	O
patient's	O
ED	O
visit	O
was	O
spurred	O
by	O
inability	O
to	O
care	O
for	O
himself	O
at	O
home	O
as	O
he	O
was	O
not	O
able	O
to	O
take	O
his	O
medications	O
regularly.	O
His	O
wife	O
was	O
also	O
admitted	O
for	O
severe	O
depression	O
and	O
inability	O
to	O
care	O
for	O
herself.	O
He	O
and	O
his	O
wife	O
have	O
been	O
considering	O
moving	O
to	O
an	O
assisted	O
living	O
facility	O
and	O
this	O
should	O
be	O
pursued	O
as	O
they	O
do	O
not	O
appear	O
safe	O
at	O
home.	O
.	O
#	O
Diabetes	O
Type	O
II/Hyperglycemia:	O
The	O
patient	O
was	O
quite	O
hyperglycemic	O
in	O
the	O
ED	O
on	O
presentation,	O
but	O
did	O
not	O
have	O
an	O
AG	O
or	O
ketones	O
in	O
his	O
urine.	O
He	O
received	O
two	O
dose	O
of	O
insulin	O
in	O
the	O
ED	O
with	O
temporary	O
normalization	O
of	O
his	O
BG.	O
However,	O
his	O
sugars	O
became	O
elevated	O
again	O
to	O
300-400s,	O
despite	O
resuming	O
home	O
diabetic	O
regimen.	O
___	O
was	O
consulted	O
and	O
recommended	O
increasing	O
his	O
insulin	O
to	O
lantus	O
13	O
units	O
qAM	O
and	O
increasing	O
glipizide	O
from	O
5mg	O
daily	O
to	O
7.5mg	O
BID.	O
He	O
was	O
also	O
covered	O
with	O
sliding	O
scale	O
insulin.	O
.	O
CHRONIC	O
ISSUES:	O
#	O
Chronic	O
Anemia:	O
Hct	O
of	O
28.8	O
on	O
admission	O
which	O
appears	O
to	O
be	O
at	O
his	O
baseline.	O
There	O
was	O
no	O
clinical	O
evidence	O
of	O
bleeding.	O
His	O
B12	O
and	O
folate	O
were	O
normal,	O
iron	O
was	O
very	O
mildly	O
decreased	O
and	O
should	O
be	O
followed	O
as	O
an	O
outpatient.	O
.	O
#	O
CLL:	O
pt	O
has	O
WBC	O
at	O
baseline	O
(___).	O
He	O
is	O
currently	O
asymptomatic	O
with	O
no	O
worsening	O
of	O
his	O
cytopenia.	O
He	O
is	O
scheduled	O
for	O
follow-up	O
with	O
hem/onc	O
in	O
3	O
months.	O
.	O
#	O
Stage	O
III	O
CKD:	O
The	O
patient's	O
creatinine	O
appears	O
to	O
be	O
at	O
baseline.	O
All	O
medications	O
were	O
renally	O
dosed.	O
.	O
#	O
History	O
of	O
CAD	O
s/p	O
CABG:	O
He	O
was	O
continued	O
on	O
metoprolol,	O
aspirin	O
and	O
lipitor.	O
.	O
#	O
Hypertension/dCHF:	O
He	O
was	O
continued	O
on	O
metopolol	O
and	O
amlodipine.	O
His	O
lasix	O
was	O
initially	O
held	O
as	O
he	O
did	O
not	O
appear	O
volume	O
overloaded.	O
This	O
was	O
resumed	O
at	O
low	O
dose	O
prior	O
to	O
discharge.	O
He	O
may	O
require	O
adjustment	O
of	O
his	O
medications	O
in	O
rehab.	O
.	O
#	O
Depression:	O
continued	O
on	O
home	O
cymbalta.	O
.	O
TRANSITIONAL	O
ISSUES:	O
Pt	O
is	O
full	O
code.	O
.	O
During	O
this	O
hospitalization,	O
pt	O
had	O
several	O
changes	O
to	O
his	O
diabetes	O
regimen,	O
including	O
increased	O
lantus	O
and	O
increased	O
glipizide.	O
This	O
should	O
be	O
monitored	O
and	O
adjusted	O
as	O
necessary	O
as	O
he	O
does	O
have	O
a	O
history	O
of	O
asymptomatic	O
hypoglycemia.	O
If	O
he	O
is	O
persistently	O
requiring	O
>4	O
unit	O
humaolog	O
with	O
meals,	O
consider	O
increasing	O
his	O
glipizide	O
to	O
10mg	O
BID.	O
.	O
Pt's	O
lasix	O
dose	O
was	O
decreased	O
during	O
this	O
hospitalization.	O
He	O
should	O
be	O
re-assessed	O
daily	O
for	O
need	O
to	O
increase	O
lasix	O
dose.	O
.	O
Pt	O
is	O
being	O
treated	O
for	O
diabetic	O
foot	O
ulcer.	O
He	O
has	O
a	O
history	O
of	O
severe	O
diabetic	O
neuropathy	O
and	O
has	O
no	O
sensation.	O
He	O
also	O
has	O
PAD	O
putting	O
him	O
at	O
increased	O
risk	O
for	O
ulcers.	O
He	O
should	O
be	O
treated	O
with	O
a	O
___long	O
with	O
daily	O
wound	O
dressings.	O
He	O
should	O
follow-up	O
with	O
podiatry	O
next	O
week.	O
If	O
wound	O
continues	O
to	O
worsen,	O
he	O
may	O
need	O
vascular	O
surgery	O
follow-up	O
given	O
severe	O
peripheral	O
arterial	O
disease.	O
.	O
Medications	O
on	O
Admission:	O
Vitamin	O
B12-Folic	O
Acid	O
0.5	O
mg-1	O
mg	O
Tab	O
Lipitor	O
40	O
mg	O
Tab	O
by	O
mouth	O
once	O
a	O
day	O
Detrol	O
LA	O
4	O
mg	O
24	O
hr	O
Cap	O
Provigil	O
200	O
mg	O
by	O
mouth	O
once	O
a	O
day	O
Fish	O
Oil	O
1,000	O
mg	O
Cap	O
Lantus	O
100	O
unit/mL	O
SubQ	O
Cartridge	O
-	O
10	O
units	O
qam	O
Centrum	O
Silver	O
Tab	O
Cymbalta	O
120	O
mg	O
QAM	O
Drisdol	O
50,000	O
unit	O
Cap	O
monthly	O
aspirin	O
325	O
mg	O
Tab	O
furosemide	O
40	O
mg	O
Tab	O
by	O
mouth	O
once	O
a	O
day	O
omeprazole	O
20	O
mg	O
BID	O
Nitroglycerin	O
0.4	O
mg	O
Sublingual	O
Tab	O
PRN	O
metoprolol	O
tartrate	O
25	O
mg	O
by	O
mouth	O
twice	O
a	O
day	O
docusate	O
sodium	O
100	O
mg	O
Cap	O
by	O
mouth	O
twice	O
daily	O
glipizide	O
5	O
mg	O
Tab	O
daily	O
in	O
AM	O
amlodipine	O
10	O
mg	O
Tab	O
daily	O
Discharge	O
Medications:	O
1.	O
senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
HS	O
(at	O
bedtime).	O
2.	O
docusate	O
sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
3.	O
atorvastatin	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
4.	O
omega-3	O
fatty	O
acids	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
DAILY	O
(Daily).	O
5.	O
metoprolol	O
tartrate	O
25	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
6.	O
Cymbalta	O
60	O
mg	O
Capsule,	O
Delayed	O
Release(E.C.)	O
Sig:	O
Two	O
(2)	O
Capsule,	O
Delayed	O
Release(E.C.)	O
PO	O
once	O
a	O
day.	O
7.	O
multivitamin	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
8.	O
aspirin	O
325	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
9.	O
omeprazole	O
20	O
mg	O
Capsule,	O
Delayed	O
Release(E.C.)	O
Sig:	O
One	O
(1)	O
Capsule,	O
Delayed	O
Release(E.C.)	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
10.	O
amlodipine	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
11.	O
Provigil	O
200	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
12.	O
cyanocobalamin	O
(vitamin	O
B-12)	O
100	O
mcg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
13.	O
Detrol	O
LA	O
4	O
mg	O
Capsule,	O
Ext	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Capsule,	O
Ext	O
Release	O
24	O
hr	O
PO	O
once	O
a	O
day.	O
14.	O
folic	O
acid	O
1	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
15.	O
insulin	O
glargine	O
100	O
unit/mL	O
Solution	O
Sig:	O
Thirteen	O
(13)	O
units	O
Subcutaneous	O
qAM.	O
16.	O
glipizide	O
5	O
mg	O
Tablet	O
Sig:	O
1.5	O
Tablets	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
17.	O
polyethylene	O
glycol	O
3350	O
17	O
gram	O
Powder	O
in	O
Packet	O
Sig:	O
One	O
(1)	O
packet	O
PO	O
DAILY	O
(Daily).	O
18.	O
furosemide	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
19.	O
sulfamethoxazole-trimethoprim	O
800-160	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day)	O
for	O
7	O
days:	O
Last	O
dose	O
___.	O
20.	O
levofloxacin	O
250	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q24H	O
(every	O
24	O
hours)	O
for	O
7	O
days:	O
Last	O
dose	O
___.	O
21.	O
Drisdol	O
50,000	O
unit	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
once	O
a	O
month.	O
22.	O
nitroglycerin	O
0.4	O
mg	O
Tablet,	O
Sublingual	O
Sig:	O
One	O
(1)	O
tablet	O
Sublingual	O
once	O
a	O
day	O
as	O
needed	O
for	O
chest	O
pain.	O
23.	O
Fish	O
Oil	O
1,000	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
once	O
a	O
day.	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary:	O
Pneumonia	B-Lower_respiratory_tract_infection
Hyperglycemia	O
hyponatremia	O
foot	O
ulcer	O
.	O
Secondary:	O
hypertension	O
hyperlipidemia	O
CHF	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___	O
___.	O
You	O
were	O
admitted	O
for	O
high	O
blood	O
sugar,	O
low	O
sodium,	O
and	O
pneumonia.	B-Lower_respiratory_tract_infection
We	O
treated	O
you	O
with	O
antibiotics.	O
We	O
also	O
gave	O
you	O
fluids	O
to	O
correct	O
your	O
sodium.	O
The	O
diabetes	O
team	O
also	O
made	O
some	O
recommendations	O
for	O
controlling	O
your	O
blood	O
sugars	O
better.	O
You	O
were	O
noted	O
to	O
have	O
an	O
ulcer	O
between	O
your	O
___	O
toes	O
on	O
the	O
right	O
foot.	O
.	O
Please	O
make	O
the	O
following	O
changes	O
to	O
your	O
medications:	O
1.	O
Increase	O
lantus	O
to	O
13	O
units	O
qAM	O
2.	O
Increase	O
glipizide	O
to	O
7.5mg	O
BID	O
3.	O
take	O
bactrim	O
DS	O
1	O
tab	O
twice	O
a	O
day	O
for	O
7	O
days	O
for	O
foot	O
ulcer	O
4.	O
take	O
levoquin	O
250mg	O
daily	O
for	O
7	O
days	O
for	O
foot	O
ulcer	O
5.	O
decrease	O
lasix	O
to	O
20	O
mg	O
daily	O
Please	O
take	O
all	O
other	O
medications	O
as	O
prescribed.	O
Weigh	O
yourself	O
every	O
morning,	O
call	O
MD	O
if	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs.	O
Followup	O
Instructions:	O
___	O

